rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ACHV
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Achieve Life Sciences Becomes AchieveRx, The Quit Company, and Will Trade Under the Ticker QUIT
      Nov 9Yahoo FinanceACHV
      Achieve Life Sciences Announces Granting of New Hire Inducement Awards

      SEATTLE and VANCOUVER, British Columbia, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty ph...

      Nov 2Business InsiderACHV
      Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX), InflaRx (IFRX) and Achieve Life Sciences (ACHV)

      Detailed price information for Achieve Life Sciences Inc (ACHV-Q) from The Globe and Mail including charting and trades.

      Oct 24The Globe and MailACHVIFRX
      H.C. Wainwright reiterates Achieve Life Sciences stock rating on trial data
      Oct 23Investing.comACHV
      Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
      Oct 21Yahoo FinanceACHV
      Achieve Life Sciences appoints Kaitlyn Tuson as SVP of marketing
      Oct 7Investing.comACHV
      Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
      Oct 7Yahoo FinanceACHV
      Achieve Life Sciences Announces Granting of New Hire Inducement Awards
      Oct 6Yahoo FinanceACHV
      Achieve Life Sciences Appoints Benjamin Halladay as CFO

      Detailed price information for Achieve Life Sciences Inc (ACHV-Q) from The Globe and Mail including charting and trades.

      Oct 2The Globe and MailACHV
      Achieve Life Sciences names Benjamin Halladay as CFO
      Oct 1Investing.comACHV
      Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer

      Brings public company CFO experience across commercial pharma and business development as Achieve prepares for potential commercialization of cytisiniclineSEATTLE and VANCOUVER, British Columbia, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced the appointment of Benjami

      Oct 1Yahoo FinanceACHV
      Achieve Life Sciences Names Benjamin Halladay CFO
      Oct 1Yahoo FinanceACHV
      Ladenburg Thalmann Initiates Wave Life Sciences at Buy With $10 Price Target
      Oct 1Yahoo FinanceACHVWVE
      Achieve a new Buy at Stifel on potential of smoking cessation drug cytisinicline
      Sep 30Seeking AlphaACHVSF
      Stifel Initiates Achieve Life Sciences at Buy With $18 Price Target
      Sep 30Yahoo FinanceACHVWVE
      Stifel initiates Achieve Life Sciences stock with buy rating
      Sep 29Investing.comACHV
      Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
      Sep 28Yahoo FinanceACHV
      Achieve Life Sciences: Thesis Intact, Setup Remains Constructive (Rating Downgrade) (ACHV)

      Achieve Life Sciences is rated a 'buy' as it nears a second NDA resubmission after resolving prior manufacturing issues. Click for this ACHV stock update.

      Sep 23Seeking AlphaACHV
      Achieve Life Sciences: A Funded Manufacturing Reset, Not A Broken Clinical Thesis
      Sep 22Seeking AlphaACHV
      Achieve Life Sciences Announced Granting of New Hire Inducement Awards

      SEATTLE and VANCOUVER, British Columbia, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment for nicotine dependence, today announced that Achieve’s board of directors approved stock option grants to purchase an aggregate of 315,000 shares of its common stock and restricted stock unit (“RSU”) awards covering an aggregate of 283,000 share

      Sep 3Yahoo FinanceACHV

      This is the newest page. Registered accounts read further back.